Luye Pharma Group(HK:2186)
HK$1.69+0.01 (+0.30%)
HK:2186
Luye Pharma Group ownership
HK$1.69
At close:+0.01 (+0.30%)
Want to see HK:2186 full AI Analyst Report?
Luye Pharma Group (2186) Ownership - Who Owns Luye Pharma Group?
3 Followers
Luye Pharma Group (2186) Ownership Overview
- 3.04% Insiders
- 2.46% Mutual Funds
- 3.74% ETFs
- 90.76% Public Companies and Individual Investors
The ownership structure of Luye Pharma Group (HK:2186) stock is a mix of institutional, retail, and individual investors. Approximately 6.20% of the company’s stock is owned by Institutional Investors, 3.04% is owned by Insiders, and 90.76% is owned by Public Companies and Individual Investors.
The ownership structure of Luye Pharma Group (HK:2186) stock is a mix of institutional, retail, and individual investors. Approximately 6.20% of the company’s stock is owned by Institutional Investors, 3.04% is owned by Insiders, and 90.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ubs Group Ag | 121,404,348 | Insider | 3.04% | 25,980,530 |
| Vanguard | 73,090,073 | Institution | 1.83% | 15,641,276 |
| Ishares | 45,498,000 | Institution | 1.14% | 9,736,572 |
| Vanguard International Equity Index Funds | 36,681,917 | Institution | 0.92% | 7,849,930 |
| Vanguard Star Funds | 30,951,539 | Institution | 0.77% | 6,623,629 |
| Dfa Investment Dimensions Group Inc | 27,151,500 | Institution | 0.68% | 5,810,421 |
| Avantis | 18,733,000 | Institution | 0.47% | 4,008,862 |
| Dimensional | 8,050,000 | Institution | 0.20% | 1,722,700 |
| State Street | 2,033,000 | Institution | 0.05% | 435,062 |
| Fidelity Salem Street Trust | 1,597,369 | Institution | 0.04% | 341,837 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 36,681,917 | Institution | 0.92% | 7,849,930 |
| Vanguard Star Funds | 30,951,539 | Institution | 0.77% | 6,623,629 |
| Dfa Investment Dimensions Group Inc | 27,151,500 | Institution | 0.68% | 5,810,421 |
| Fidelity Salem Street Trust | 1,597,369 | Institution | 0.04% | 341,837 |
| American Century Etf Trust | 596,000 | Institution | 0.01% | 127,544 |
| Harbor Funds | 440,500 | Institution | 0.01% | 94,267 |
| State Street Institutional Investment Trust | 416,000 | Institution | 0.01% | 89,024 |
| Eaton Vance Mutual Funds Trust | 249,500 | Institution | <0.01% | 53,393 |
| John Hancock Variable Insurance Trust | 189,500 | Institution | <0.01% | 40,553 |
| Franklin Alternative Strategies Funds | 1 | Institution | 0.00% | 0 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total International Stock ETF, VXUS ETF | 32,427,039 | Institution | 0.81% | 7,811,814 |
| Vanguard FTSE Emerging Markets ETF, VWO ETF | 30,731,956 | Institution | 0.77% | 7,403,461 |
| iShares Core MSCI Emerging Markets ETF, IEMG ETF | 25,189,000 | Institution | 0.63% | 5,405,255 |
| Avantis Emerging Markets Equity ETF, AVEM ETF | 16,365,000 | Institution | 0.41% | 3,493,858 |
| Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF | 7,501,500 | Institution | 0.19% | 1,807,142 |
| Dimensional Emerging Markets Core Equity 2 ETF, DFEM ETF | 3,694,500 | Institution | 0.09% | 791,174 |
| iShares Core MSCI Total International Stock ETF, IXUS ETF | 3,040,500 | Institution | 0.08% | 652,455 |
| Dimensional Emerging Core Equity Market ETF, DFAE ETF | 2,142,000 | Institution | 0.05% | 458,707 |
| Vanguard Total World Stock ETF, VT ETF | 1,891,500 | Institution | 0.05% | 455,670 |
| Avantis Emerging Markets Value ETF, AVES ETF | 1,884,000 | Institution | 0.05% | 402,226 |
FAQ
Who Owns Luye Pharma Group (HK:2186)?
According to the latest TipRanks data, approximately 6.20% of the company's stock is held by institutional investors, 3.04% is held by insiders, and 90.76% is held by public companies and individual investors.
What percentage of Luye Pharma Group (HK:2186) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.20% of Luye Pharma Group (HK:2186) stock is held by institutional investors: 2.46% by mutual funds and 3.74% by ETFs.
What percentage of Luye Pharma Group (HK:2186) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.76% of Luye Pharma Group (HK:2186) stock is held by public companies and individual investors.
Who owns the most shares of Luye Pharma Group (HK:2186)?
UBS Group Ag owns the most shares of Luye Pharma Group (HK:2186).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
